Over the years, sampling programs have been an effective approach for doctors and patients to have access to innovative, chronic, and life-saving medication. However, due to the process being largely manual, pharmaceutical companies faced challenges in controlling and managing the samples to the doctors as well as identifying the eligibility of recipients.
